These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15283938)

  • 21. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women.
    Hemelaar M; van der Mooren MJ; van Baal WM; Schalkwijk CG; Kenemans P; Stehouwer CD
    Menopause; 2005; 12(5):526-35. PubMed ID: 16145306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uterine blood flow response to hormonal replacement therapy in asymptomatic postmenopausal women: a transvaginal Doppler study.
    Tanawattanacharoen S; Panyakhamlerd K; Chaikittisilpa S; Taechakraichana N; Limpaphayom KK
    J Med Assoc Thai; 2000 Apr; 83(4):368-73. PubMed ID: 10808696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of different postmenopausal hormone therapy regimens on cerebral blood flow and cognitive functions.
    Guvenal T; Durna A; Erden O; Guvenal F; Cetin M; Cetin A
    Adv Ther; 2009 Aug; 26(8):805-11. PubMed ID: 19672567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
    Ziaei S; Moaya M; Faghihzadeh S
    Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of hormone replacement therapy in postmenopausal women by transvaginal sonography and color flow doppler: study in different phases of sequential therapy.
    Exacoustòs C; Lello S; Caporale E; Minghetti MC; Angelozzi D; Arduini D; Romanini C
    Fertil Steril; 1999 Mar; 71(3):536-43. PubMed ID: 10065794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of serum estrogen levels with uterine and carotid arteries flow in postmenopausal women on hormone replacement therapy.
    Predanic M; Ujevic B; Aleem F; Pennisi J
    Croat Med J; 1998 Jun; 39(2):181-4. PubMed ID: 9575274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular resistance of central retinal and ophthalmic arteries in postmenopausal women after use of tibolone.
    de Souza MA; de Souza BM; Geber S
    Menopause; 2012 Mar; 19(3):328-31. PubMed ID: 22042323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA; Wang ST; Pai MC; Chen CH; Wu MH; Huang KE
    J Reprod Med; 2003 May; 48(5):375-80. PubMed ID: 12815913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differential effects on serum IGF-1 of tibolone (5 mg/day) vs combined continuous estrogen/progestagen in post menopausal women].
    Porcile A; Gallardo E; Duarte P; Aedo S
    Rev Med Chil; 2003 Oct; 131(10):1151-6. PubMed ID: 14692305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow.
    Cacciatore B; Paakkari I; Toivonen J; Tikkanen MJ; Ylikorkala O
    Obstet Gynecol; 1998 Oct; 92(4 Pt 1):563-8. PubMed ID: 9764629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time since menopause does not affect plasma viscosity, plasma thromboxane levels and Doppler findings.
    Mancini F; Persico N; Regnani G; Volpe A; Battaglia C; de Aloysio D
    Gynecol Endocrinol; 2005 Mar; 20(3):170-5. PubMed ID: 16019357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
    Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy in postmenopausal women with benign fibrocystic mastopathy.
    Yenen MC; Dede M; Goktolga U; Kuçuk T; Pabuçcu R
    Climacteric; 2003 Jun; 6(2):146-50. PubMed ID: 12841885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS; Carlström K; Jonsson B; Jonasson AF
    Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B.
    Castelo-Branco C; Casals E; Figueras F; Sanjuan A; Vicente JJ; Balasch J; Vanrell JA
    Menopause; 1999; 6(2):92-7. PubMed ID: 10374214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal hormone replacement therapy and Doppler findings in normal and overweight postmenopausal patients.
    Persico N; Mancini F; Artini PG; Regnani G; Volpe A; de Aloysio D; Battaglia C
    Gynecol Endocrinol; 2004 Nov; 19(5):274-81. PubMed ID: 15726916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study.
    Koh KK; Han SH; Shin MS; Ahn JY; Lee Y; Shin EK
    Eur Heart J; 2005 Jul; 26(14):1362-8. PubMed ID: 15872028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.